International Journal of Neuroscience
For a look at what's changing across the board, see our breakdown of Medicare Advantage trends and changes for 2026
Whether either brand-name option is prescribed instead of a compounded one is a decision that belongs entirely to the evaluating clinician
Stick with the lowest dose to avoid side effects, and patients complain of not seeing results fast enough, causing churn anyway
DOI: 10.1016/j.phrs.2018.03.004 [Google Scholar] Hendarto H, Inoguchi T, Maeda Y, Ikeda N, Zheng J, Takei R, et al
The FDA-approved tesamorelin product comes with its own diluent and mixing instructions from the manufacturer